Alaunos Therapeutics, Inc. 8-K

What Happened
On June 29, 2026, Alaunos Therapeutics (TCRT) issued a press release and filed an 8-K reporting a new preclinical statistical analysis from its previously disclosed non‑GLP, 48‑day diet‑induced obesity (DIO) mouse Study 1 of ALN1003. The company reported that ALN1003‑treated animals had lower liver weight than controls after adjustment for body fat percentage using a standard ANCOVA, and the result was confirmed using heteroscedasticity‑robust HC3 standard errors as a sensitivity analysis. Alaunos said this suggests the lower liver weight with ALN1003 was not fully explained by measured body fat percentage. The company also posted an investor presentation (May 2026) with integrated data, statistical analyses and representative liver histology images.

Key Details

• Date filed/announced: June 29, 2026.
• Study: 48‑day non‑GLP diet‑induced obesity (DIO) mouse Study 1.
• Result: ALN1003‑treated mice showed lower liver weight versus controls after adjusting for body fat % (ANCOVA; HC3 robust SEs confirmed).
• Materials: Press release furnished as Exhibit 99.1; non‑confidential investor presentation available on the company website (May 2026).
• Disclaimers: Findings are from non‑GLP mouse studies; ALN1003 has not been evaluated in human trials and safety/efficacy in humans are not established.

Why It Matters
This filing highlights a preclinical signal that ALN1003 may reduce liver weight independently of measured body fat in a mouse obesity model, and the result is directionally consistent with other reported liver markers, selected histology, HOMA‑IR and adipose endocrine biomarker findings. For investors, this is an early scientific finding that could support the candidate’s therapeutic rationale in metabolic disease if replicated under GLP and in clinical trials. However, it is strictly preclinical (non‑GLP) data from mice and may not translate to humans; ALN1003 has not entered human clinical testing, so no conclusions about safety, efficacy, or commercial impact can be drawn yet.